PARP and CDK4/6 inhibitor combination therapy induces apoptosis and suppresses neuroendocrine differentiation in prostate cancer

Cheng Wu, Shan Peng, Patrick G. Pilie, Chuandong Geng, Sanghee Park, Ganiraju C. Manyam, Yungang Lu, Guang Yang, Zhe Tang, Shakuntala Kondraganti, Daoqi Wang, Courtney W. Hudgens, Debora A. Ledesma, Mario L. Marques-Piubelli, Carlos A. Torres-Cabala, Jonathan L. Curry, Patricia Troncoso, Paul G. Corn, Bradley M. Broom, Timothy C. Thompson

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'PARP and CDK4/6 inhibitor combination therapy induces apoptosis and suppresses neuroendocrine differentiation in prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences